T-CURX

Series-A
t-curx.com Biotech & Healthcare Würzburg, Germany
Total Funding $20M
Latest Round $20M Series-A
Last Announced Dec 17, 2025
Investors 4 Backers
Decision Makers Profile Active

About T-CURX

We envision a future in which the curative potential of CAR-T therapies can benefit many more cancer patients – without the cost and complexity of conventional viral cell manufacturing.

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-A
Global Headquarters Würzburg, Germany
Tracked Since Nov 8, 2026

Web & Domain Identity

Official Website t-curx.com
Domain Registered Date Undisclosed

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Company Profile

Company Milestones & Timeline

1 Events
  1. Capital Raise

    Raised $20,000,000 · Series-A

    t-curx.com

Investors & Backers

4
Bayern Kapital
BioMedPartners
Highlight Capital
i&i Biotech Fund

Funding History

1 Round
Series-A equity · Dec 17, 2025
$20,000,000 t-curx.com

Founders & Leadership

3

Christoph Rader

Founder

Work email & phone locked Unlock →

Michael Hudecek

Chief Medical Officer & Co-Founder

Work email & phone locked Unlock →

Ulf Grawunder

Chief Executive Officer & Co-Founder

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

Recently funded startups
New SaaS launches
Never pay twice for contacts